Dr. Zarwan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Mall Rd
# Lahey
Burlington, MA 01805Phone+1 781-744-8400Fax+1 781-744-5245
Summary
- Dr. Corrine Zarwan is an oncologist in Burlington, MA and is affiliated with multiple hospitals in the area, including Lahey Hospital & Medical Center, Beverly Hospital, and Winchester Hospital. She received her medical degree from University of Florida College of Medicine and has been in practice 17 years. She is experienced in breast cancer, hereditary breast/ovarian cancer, gynecologic cancer, familial breast/ovarian cancer, and clinical research. She has more than 10 publications and over 500 citings.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2005
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of Florida College of MedicineClass of 2000
Certifications & Licensure
- NH State Medical License 2024 - 2026
- MA State Medical License 2002 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Join now to see all
Publications & Presentations
PubMed
- 45 citationsUpfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case seriesSarju Ganatra, Anju Nohria, Sachin P. Shah, John D. Groarke, Ajay K. Sharma
Cardio-Oncology. 2019-01-29 - 219 citationsCediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal ...Ursula A. Matulonis, Suzanne Berlin, Percy Ivy, Karin Tyburski, Carolyn N. Krasner
Journal of Clinical Oncology. 2009-11-20 - 50 citationsAppropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline UpdateJennifer J. Griggs, Kari Bohlke, Edward P. Balaban, James J. Dignam, Evan T. Hall
Journal of Clinical Oncology. 2021-05-03
Press Mentions
- Clinical Trials 101: What You Need to KnowJanuary 8th, 2019
- Cancer Survivor Teresa Gately Touts Clinical Trials and Positive Attitude in Fighting DiseaseAugust 23rd, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: